Compare Fulford India with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs NEULAND LABS - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA NEULAND LABS FULFORD INDIA/
NEULAND LABS
 
P/E (TTM) x 398.8 53.9 740.2% View Chart
P/BV x 6.2 4.1 152.5% View Chart
Dividend Yield % 0.1 0.1 95.5%  

Financials

 FULFORD INDIA   NEULAND LABS
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
NEULAND LABS
Mar-20
FULFORD INDIA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs942754 125.0%   
Low Rs450247 182.0%   
Sales per share (Unadj.) Rs691.4594.5 116.3%  
Earnings per share (Unadj.) Rs11.512.6 90.7%  
Cash flow per share (Unadj.) Rs15.437.0 41.5%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.4 71.9%  
Book value per share (Unadj.) Rs380.0553.4 68.7%  
Shares outstanding (eoy) m3.9012.83 30.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.8 119.6%   
Avg P/E ratio x60.739.6 153.3%  
P/CF ratio (eoy) x45.313.5 335.2%  
Price / Book Value ratio x1.80.9 202.5%  
Dividend payout %17.415.8 110.2%   
Avg Mkt Cap Rs m2,7146,421 42.3%   
No. of employees `0000.41.3 34.6%   
Total wages/salary Rs m5051,236 40.9%   
Avg. sales/employee Rs Th6,073.05,949.4 102.1%   
Avg. wages/employee Rs Th1,137.4963.8 118.0%   
Avg. net profit/employee Rs Th100.7126.4 79.6%   
INCOME DATA
Net Sales Rs m2,6967,627 35.4%  
Other income Rs m12539 322.8%   
Total revenues Rs m2,8227,666 36.8%   
Gross profit Rs m-461,019 -4.6%  
Depreciation Rs m15313 4.9%   
Interest Rs m10216 4.4%   
Profit before tax Rs m54529 10.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10367 2.6%   
Profit after tax Rs m45162 27.6%  
Gross profit margin %-1.713.4 -12.9%  
Effective tax rate %17.769.4 25.5%   
Net profit margin %1.72.1 78.0%  
BALANCE SHEET DATA
Current assets Rs m1,7385,152 33.7%   
Current liabilities Rs m5453,576 15.2%   
Net working cap to sales %44.320.7 214.3%  
Current ratio x3.21.4 221.5%  
Inventory Days Days48105 46.1%  
Debtors Days Days491 4.7%  
Net fixed assets Rs m123,969 0.3%   
Share capital Rs m39129 30.2%   
"Free" reserves Rs m1,4436,971 20.7%   
Net worth Rs m1,4827,100 20.9%   
Long term debt Rs m0774 0.0%   
Total assets Rs m2,07712,310 16.9%  
Interest coverage x6.73.5 194.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 209.6%   
Return on assets %2.63.1 85.0%  
Return on equity %3.02.3 132.1%  
Return on capital %4.39.5 45.5%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m175,187 0.3%   
Fx outflow Rs m6731,593 42.3%   
Net fx Rs m-6563,594 -18.3%   
CASH FLOW
From Operations Rs m90573 15.7%  
From Investments Rs m105-487 -21.5%  
From Financial Activity Rs m-14-55 25.7%  
Net Cashflow Rs m18133 553.7%  

Share Holding

Indian Promoters % 0.0 36.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 63.7 6.0%  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 63.7 33.3%  
Shareholders   4,783 12,705 37.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS